Navigation Links
MiMedx To Present At Canaccord Genuity Medical Technology And Diagnostics Forum
Date:10/31/2013

MARIETTA, Ga., Oct. 31, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York, New York.  Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on November 14, 2013 at 9:00 a.m. EST at the Westin Grand Central Hotel.  A webcast of this presentation will be available on the Company's website, www.mimedx.com

About MiMedx
MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include AmnioFix® and EpiFix®, our tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® process, to produce a safe and effective implant. MiMedx® is the leading supplier of amniotic tissue, having supplied over 190,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental s
'/>"/>

SOURCE MiMedx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Announces Record Third Quarter Results
2. MiMedx Reports On Meeting With FDA
3. MiMedx Responds To Misleading And Inaccurate Media Reports
4. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
5. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
6. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
7. MiMedx Announces Record Second Quarter Results
8. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
9. MiMedx To Exceed High End Of Second Quarter Guidance
10. MiMedx to Ring NASDAQ Stock Market Opening Bell
11. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... UK (PRWEB) October 30, 2014 Caustic soda ... epoxy resins and polycarbonates. At present, China takes lead in ... , Dow, which possesses a number of facilities in the ... in the world caustic soda market in terms of output ... forecast to grow on average by 3% per year in ...
(Date:10/31/2014)... 31, 2014 Jeffrey T. Manuel, assistant ... Studies within the College of Arts and Sciences, is ... the history of alcohol-based fuels in Illinois. , ... have been working to build Illinois’ biofuels industry for ... aspect of the state's agricultural and business history. ...
(Date:10/31/2014)... October 31, 2014 The report ... Rice), Formulation (Plain, Flavored, Sweetened, Unsweetened), Channel (Supermarket, ... Global Trends & Forecast to 2018," defines and ... analysis and forecast of revenue and volume for ... is projected to reach $14 Billion by 2018 ...
(Date:10/31/2014)... 31, 2014 Stronger investment from ... finance and consumer electronics will help fuel new ... research firm IBISWorld has added a report on ... industry report collection. , The Biometrics Scan Software ... technologies such as fingerprint, iris, retina and face ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 2SIUE History Prof Manuel Working on Biofuels Book with NCERC 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3
... , , , , , , ... for nucleic acid amplification. For detailed information about a product , please ... Protector , RNase Inhibitor , , ... , is a new type of RNase ...
... , , , , , , ... size of template , Temperature optimum , Units needed for ... Rnase H activity , Combined RT and DNA Pol. , ... Expand Re- , verse Trans- , ...
... PCR that is as Flexible , as , ... , , , Choose the ... to meet your changing research needs. Central to the LightCycler , ... more than "Just another thermal cycler". It is a completely new integrated , ...
Cached Biology Technology:Product overview 2Product overview 3Product overview 4Product overview 5Product overview 6Product overview 7Properties of Reverse Transcriptases 2The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 2The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 3The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 4
(Date:10/31/2014)... emits over a wide part of the electromagnetic spectrum ... built in Lund, Sweden. The MAX IV facility presents ... together its component parts in a storage - ring ... a few hundred metres. Nevertheless, if these various challenges ... experiments that require source brightness and transverse coherence will ...
(Date:10/31/2014)... Ebola one important hurdle has just been cleared – ... of North Carolina at Chapel Hill and colleagues have ... be infected with Ebola and display symptoms similar to ... current issue of Science , will significantly improve ... desperately needed to curb the worldwide public health and ...
(Date:10/31/2014)...  HITLAB SM , a healthcare innovation and ... HITLAB Innovators Summit SM on December 1, ... partner with the Clinton Foundation,s Health Matters Initiative, ... Business School Alumni Club of New ... Operations Research, bringing together leaders in healthcare and ...
Breaking Biology News(10 mins):A new generation of storage -- ring 2Improved mouse model will accelerate research on potential Ebola vaccines, treatments 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3
... PHILADELPHIA (December 8, 2013) According to Gertrude Stein, "A ... indicates that might not be the case when it comes ... collaborating institutions have found that as much as 30 percent ... any two individuals. This substantial variation is in turn reflected ...
... items to freezing temperatures may be a viable control option ... new study has found that bed bugs may be less ... article in the Journal of Economic Entomology called ... the authors describe how exposing bed bugs to freezing temperatures ...
... ORLEANS, December 7, 2013) Hematopoietic stem cell transplantation ... drug therapy for blood cancer, has become more accessible ... a result of major advances in transplant strategies and ... during the 55th American Society of Hematology Annual Meeting ...
Cached Biology News:Extensive variability in olfactory receptors influences human odor perception 2International gene therapy trial for 'bubble boy' disease shows promising early results 2International gene therapy trial for 'bubble boy' disease shows promising early results 3International gene therapy trial for 'bubble boy' disease shows promising early results 4International gene therapy trial for 'bubble boy' disease shows promising early results 5International gene therapy trial for 'bubble boy' disease shows promising early results 6International gene therapy trial for 'bubble boy' disease shows promising early results 7
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... Automation Buffer is a concentrated formulation of ... employing capillary action technology, as well as ... collaboration with David Brigati M.D., Department of ... This buffer is recommended for all the ...
...
... users requiring mass detection but not ... TOF Mass spectrometer is ideally suited ... for high performance mass analysis. ... analysis, protein detection, micro-satellite DNA characterization ...
Biology Products: